
Sellas Life Sciences Group Inc
SLSNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$9.20
Day High
$9.51
Day Low
$8.60
Prev. Close
$9.18
VolumeShares traded today.
24.71M
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$1.73B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-40.03
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$9.51
52W LowLowest price over the past 52 weeks.
$1.39
50D MAAverage closing price over the last 50 trading days.
$5.58
200D MAAverage closing price over the last 200 trading days.
$3.46
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+23.1%1M
+99.4%6M
+546.5%YTD
+114.0%1Y
+444.4%About
Galena Biopharma, Inc. was a publicly traded pharmaceutical company based in San Ramon, California. The company was founded in Worcester, Massachusetts. In 2011, it moved to Oregon, and in 2015 moved to San Ramon, California. Mark Schwartz was the company's president and chief executive officer. As of December 29, 2017, the company was acquired by Sellas Life Sciences Group Ltd. through a reverse merger transaction. Galena Biopharma was renamed to Sellas Life Sciences Group, Inc..
www.sellaslifesciences.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade SLS
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.